Weidinger G - Search Results

1

Pimecrolimus cream in the long-term management of atopic dermatitis in adults: a six-month study.

Meurer M, Fölster-Holst R, Wozel G, Weidinger G, Jünger M, Bräutigam M; CASM-DE-01 study group. Meurer M, et al. Among authors: weidinger g. Dermatology. 2002;205(3):271-7. doi: 10.1159/000065863. Dermatology. 2002. PMID: 12399676 Clinical Trial.

2

Long-term efficacy and safety of pimecrolimus cream 1% in adults with moderate atopic dermatitis.

Meurer M, Fartasch M, Albrecht G, Vogt T, Worm M, Ruzicka T, Altmeyer PJ, Schneider D, Weidinger G, Braeutigam M; CASM-DE-01 Study Group. Meurer M, et al. Among authors: weidinger g. Dermatology. 2004;208(4):365-72. doi: 10.1159/000078462. Dermatology. 2004. PMID: 15178928 Clinical Trial.

3

A body-weight-independent dosing regimen of cyclosporine microemulsion is effective in severe atopic dermatitis and improves the quality of life.

Czech W, Bräutigam M, Weidinger G, Schöpf E. Czech W, et al. Among authors: weidinger g. J Am Acad Dermatol. 2000 Apr;42(4):653-9. J Am Acad Dermatol. 2000. PMID: 10727313 Clinical Trial.

4

Body-weight-independent dosing of cyclosporine micro-emulsion and three times weekly maintenance regimen in severe psoriasis. A randomised study.

Thaçi D, Bräutigam M, Kaufmann R, Weidinger G, Paul C, Christophers E. Thaçi D, et al. Among authors: weidinger g. Dermatology. 2002;205(4):383-8. doi: 10.1159/000066425. Dermatology. 2002. PMID: 12444336 Clinical Trial.

5

The novel ascomycin derivative SDZ ASM 981 is effective for psoriasis when used topically under occlusion.

Mrowietz U, Graeber M, Bräutigam M, Thurston M, Wagenaar A, Weidinger G, Christophers E. Mrowietz U, et al. Among authors: weidinger g. Br J Dermatol. 1998 Dec;139(6):992-6. doi: 10.1046/j.1365-2133.1998.02554.x. Br J Dermatol. 1998. PMID: 9990361 Clinical Trial.

6

Evaluation of 6 weeks treatment of terbinafine in tinea unguium in a double-blind trial comparing 6 and 12 weeks therapy. The Lagos V Study Group.

Tausch I, Bräutigam M, Weidinger G, Jones TC. Tausch I, et al. Among authors: weidinger g. Br J Dermatol. 1997 May;136(5):737-42. Br J Dermatol. 1997. PMID: 9205509 Clinical Trial.

7

Short duration treatment with terbinafine for tinea capitis caused by Trichophyton or Microsporum species. The Study Group.

Hamm H, Schwinn A, Bräutigam M, Weidinger G. Hamm H, et al. Among authors: weidinger g. Br J Dermatol. 1999 Mar;140(3):480-2. doi: 10.1046/j.1365-2133.1999.02713.x. Br J Dermatol. 1999. PMID: 10233270 Clinical Trial.

8

Low-dose cyclosporin A microemulsion in children with severe atopic dermatitis: clinical and immunological effects.

Bunikowski R, Staab D, Kussebi F, Bräutigam M, Weidinger G, Renz H, Wahn U. Bunikowski R, et al. Among authors: weidinger g. Pediatr Allergy Immunol. 2001 Aug;12(4):216-23. doi: 10.1034/j.1399-3038.2001.012004216.x. Pediatr Allergy Immunol. 2001. PMID: 11555319 Clinical Trial.

9

Low-dose (1.25 mg/kg) cyclosporin A: treatment of psoriasis and investigation of the influence on lipid profile.

Meffert H, Bräutigam M, Färber L, Weidinger G. Meffert H, et al. Among authors: weidinger g. Acta Derm Venereol. 1997 Mar;77(2):137-41. doi: 10.2340/0001555577137141. Acta Derm Venereol. 1997. PMID: 9111826 Free article. Clinical Trial.

10

Short-duration treatment of fingernail dermatophytosis: a randomized, double-blind study with terbinafine and griseofulvin. LAGOS III Study Group.

Haneke E, Tausch I, Bräutigam M, Weidinger G, Welzel D. Haneke E, et al. Among authors: weidinger g. J Am Acad Dermatol. 1995 Jan;32(1):72-7. doi: 10.1016/0190-9622(95)90187-6. J Am Acad Dermatol. 1995. PMID: 7822520 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

179 results

Search Page

Filters